| CBA2 Human Breast Cancer |
| |
Sex |
Age |
Organ |
Diagnosis |
T stage |
LN* |
ER** |
PR** |
p53 |
| 1 |
F |
28 |
Breast |
infiltrating duct carcinoma
|
T4 |
uk |
+ |
- |
- |
| 2 |
F |
71 |
Breast |
solid papillary carcinoma
|
T4b |
2/12 |
+ |
+ |
- |
| 3 |
F |
26 |
Breast |
infiltrating duct carcinoma
|
T4b |
22/25 |
+ |
- |
- |
| 4 |
F |
43 |
Breast |
infiltrating duct carcinoma
|
T4b |
4/13 |
+ |
+ |
- |
| 5 |
F |
39 |
Breast |
infiltrating duct carcinoma
|
T3 |
0/37 |
- |
- |
+ |
| 6 |
F |
46 |
Breast |
ductal carcinoma in situ
|
T3 |
14/15 |
+ |
+ |
- |
| 7 |
F |
47 |
Breast |
infiltrating duct carcinoma
|
T2 |
37/41 |
- |
- |
+ |
| 8 |
M |
67 |
Breast |
infiltrating duct carcinoma
|
T3 |
1/12 |
+ |
+ |
- |
| 9 |
F |
33 |
Breast |
infiltrating duct carcinoma
|
T3 |
25/25 |
+ |
+ |
- |
| 10 |
F |
47 |
Breast |
infiltrating duct carcinoma
|
T2 |
0/15 |
+ |
+ |
- |
| 11 |
F |
49 |
Breast |
infiltrating lobular carcinoma
|
T2 |
1/14 |
- |
- |
- |
| 12 |
F |
46 |
Breast |
infiltrating duct carcinoma
|
T3 |
2/25 |
+ |
- |
- |
| 13 |
F |
39 |
Breast |
infiltrating duct carcinoma
|
T2 |
2/19 |
+ |
uk |
- |
| 14 |
F |
43 |
Breast |
infiltrating lobular carcinoma
|
T3 |
25/25 |
- |
- |
- |
| 15 |
F |
54 |
Breast |
infiltrating lobular carcinoma
|
T3 |
28/31 |
+ |
- |
+ |
| 16 |
F |
58 |
Breast |
infiltrating duct carcinoma
|
T4b |
1/15 |
- |
- |
- |
| 17 |
F |
37 |
Breast |
infiltrating duct carcinoma
|
T2 |
2/14 |
+ |
+ |
+ |
| 18 |
F |
43 |
Breast |
infiltrating duct carcinoma
|
T2 |
0/13 |
- |
- |
+ |
| 19 |
F |
51 |
Breast |
infiltrating duct carcinoma
|
T2 |
0/20 |
+ |
+ |
- |
| 20 |
F |
80 |
Breast |
medullary carcinoma |
T3 |
4/28 |
|